Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Obesity and metabolic syndrome are growing epidemics worldwide and greatly responsible for many liver diseases, including nonalcoholic fatty liver disease (NAFLD). NAFLD often progresses to cirrhosis, end-stage liver failure and hepatocellular carcinoma (HCC), the most common primary liver cancer an...
Main Authors: | Marta B. Afonso, Pedro M. Rodrigues, André L. Simão, Rui E. Castro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/5/3/30 |
Similar Items
-
Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population
by: Sneha S. Pillai, et al.
Published: (2020-09-01) -
Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01) -
Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease
by: José Tadeu Stefano, et al.
Published: (2021-01-01) -
Multiple MicroRNAs Ameliorate Hepatocyte Steatosis and Injury by Suppressing FABP1 Expression
by: Yun-li Wu, et al.
Published: (2017-12-01) -
The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
by: Tomomi Kogiso, et al.
Published: (2021-01-01)